Topcare Nicotine Polacrilex
Product Images NDC 36800-344

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topcare Nicotine Polacrilex (NDC 36800-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Topco Associates Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

344 88 Nicotine Lozenge Image 1

This appears to be a description of a 2mg Nicotine Lozenge that is used as a stop-smoking aid. The product is manufactured by TopCare and the package includes the user's guide. The provided text includes some gibberish words and characters that may have been incorrectly recognized by the system.*

FDA Label Image

344 88 Nicotine Lozenge Image 2

This appears to be the information and directions leaflet for a nicotine lozenge that helps quitting smoking. It contains instructions on how to use the product as well as warnings and essential information about its ingredients.*

FDA Label Image

Wallet_card (Image 01)

The text provides information about a Wallet Card that includes contact numbers to call for help in case of medical emergencies or assistance related to quitting smoking. The Wallet Card includes numbers for the American Lung Association, American Cancer Society, American Heart Association, and a reference to a "Quitting Buddy" or a "Friend who has Quit".*

FDA Label Image

Wallet‑_card (Image 02)

FDA Label Image

Smoke_free_logo (Image 03)

FDA Label Image

Upc_example (Image 04)

This is not-available as it is just a series of numbers and a UPC code without any human-readable text.*

FDA Label Image

Stickers (Image 05)

The text describes reminders for a calendar associated with quitting smoking. It provides specific instructions for taking nicotine lozenges during the quitting process based on the week since the quit date. It suggests taking one lozenge every 1 to 2 hours during the first week, then 1 lozenge every 2 to 4 hours during week 3, and finally 1 lozenge every 4 to 8 hours during week 7. It also mentions a reminder for week 10 and 12 after the quit date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.